REMS
Spectrum:
Absorption: IV administration results in complete bioavailability.
Distribution: Widely distributed with good penetration into gall bladder, lung, and colon.
Half-Life: 27.1 hr (after 1 dose); 42.4 hr after multiple doses.
Contraindicated in:
Use Cautiously in:
Derm: STEVENS-JOHNSON SYNDROME (SJS)
Endo: hyperglycemia, hypoglycemia
F and E: hypocalcemia, hyponatremia
GI: nausea, vomiting, ↑liver enzymes, anorexia, CLOSTRIDIOIDES DIFFICILE-ASSOCIATED DIARRHEA (CDAD), dry mouth, jaundice, PANCREATITIS
GU: ↑serum creatinine
Hemat: hypofibrinogenemia
Local: injection site reactions
Neuro: dysgeusia, somnolence
Resp: pneumonia
Misc: DEATH, HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS)
Drug-drug:
Hepatic Impairment
Lab Test Considerations:
IV Administration: